This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Metadate ER Tablets CII

UCB SA

Drug Names(s): generic methylphenidate HCL extended release tablet

Description: BioMedTracker has a separate drug profile for Metadate CD CII.

Metadate ER tablet is an extended release tablet formulation of methylphenidate, the active ingredient in Ritalin (R). It is given two to three times daily.

Methylphenidate is a central nervous system (CNS) stimulant that has a calming effect on many children who have ADHD. Although the precise mechanism of action is not known, it is thought to inhibit the reuptake of norepinephrine and dopamine in the presynaptic neuron (the neuron that is stimulating/inhibiting the connecting neuron) and increase release of these chemicals into the space outside the neurons.


Metadate ER Tablets CII News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug